|
|
H2020/CTD7980/16504
|
DOLUTEGRAVIR (AS SODIUM) , LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50 MG/300 MG/ 300 MG
|
DOLUTEGRAVIR (AS SODIUM) , LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
H2020/CTD7079/13566
|
DOLUTEGRAVIR 50MG , LAMIVUDINE 300MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS
|
DOLUTEGRAVIR SODIUM,LAMIVUDINE USP TENOFOVIR DISOPROXIL FUMARATE
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2022/CTD8196/17724
|
DOLUTEGRAVIR AND LAMIVUDINE 50/300 MG TABLET
|
DOLUTEGRAVIR SODIUM AND LAMIVUDINE
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
CTD7411
|
DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG/ 300 MG/300 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2019/CTD7411/14564
|
DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG/ 300 MG/300 MG TABLETS
|
EACH FILM COATED TABLET CONTAINS 52.6 MG OF DOLUTEGRAVIR SODIUM EQUIVALENT TO 50 MG OF DOLUTEGRAVIR, 300 MG OF LAMIVUDINE USP AND 300 MG OF TENOFOVIR DISOPROXIL FUMARATE (EQUIVALENT TO 245 MG OF TENOFOVIR DISOPROXIL).
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2022/CTD8624/19193
|
DOLUTEGRAVIR SODIUM TABLET FOR ORAL SUSPENSION (DISPERSIBLE TABLETS) 10MG
|
DOLUTEGRAVIR SODIUM
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2021/CTD8639/19826
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50/300/300 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
EVKA CONSULTZ LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9776/21543
|
DOLUTEGRAVIR TABLETS 50 MG
|
DOLUTEGRAVIR (AS SODIUM)
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2021/CTD6525/12808
|
DOLUTEGRAVIR TABLETS 50 MG
|
DOLUTEGRAVIR SODIUM
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2025/CTD10569/22997
|
DOLUTEGRAVIR TABLETS 50MG
|
DOLUTEGRAVIR SODIUM
|
MICRO LABS (EA) LTD
|
Registered
|
Details →
|
|
|
CTD5930
|
DOLUTEGRAVIR TABLETS 50MG
|
DOLUTEGRAVIR SODIUM.
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2020/CTD7672/14855
|
DOLUTEGRAVIR TABLETS 50MG
|
DOLUTEGRAVIR
|
DAWA LTD
|
Registered
|
Details →
|
|
|
H2016/CTD4043/034
|
DOLUTEGRAVIR TABLETS 50MG
|
DOLUTEGRAVIR SODIUM EQUIVALENT TO DOLUTEGRAVIR 50MG
|
SIMBA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9302/20844
|
DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG / 200 MG / 25 MG
|
DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG / 200 MG / 25 MG
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9547/18539
|
DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG/200 MG/25 MG
|
DOLUTEGRAVIR SODIUM, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
|
DAWA LTD
|
Registered
|
Details →
|
|
|
H2026/CTD12201/24556
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG, 300 MG AND 25 MG
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG, 300 MG AND 25 MG
|
NAIROBI ENTERPRISES LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10906/21966
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG/300 MG/25 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE FUMARATE
|
DAWA LTD
|
Registered
|
Details →
|
|
|
H2021/CTD8566/18403
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
TIBA HEALTHCARE LIMITED
|
Registered
|
Details →
|
|
|
H2025/CTD11527/23967
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG / 300 MG / 300 MG TABLETS
|
DOLUTEGRAVIR, LAMIVUDINE & TENOFOVIR DISOPROXIL FUMARATE
|
MICRO LABS (EA) LTD
|
Registered
|
Details →
|
|
|
H2019/CTD7486/14555
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
DAWA LTD
|
Registered
|
Details →
|